Detalhe da pesquisa
1.
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
J Transl Med
; 13: 139, 2015 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-25933939
2.
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe.
Cancers (Basel)
; 14(21)2022 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36358770
3.
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Clin Cancer Res
; 25(17): 5231-5241, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31171545
4.
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Cancer Res
; 66(9): 4943-51, 2006 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16651452
5.
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
Blood Transfus
; 13(3): 464-71, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25761309
6.
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals.
Vaccine
; 26(8): 1038-49, 2008 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-18249478